The Pitfalls of Deducing Ethics From Behavioral Economics: Why the Association of American Medical Colleges Is Wrong About Pharmaceutical Detailing
The Pitfalls of Deducing Ethics From Behavioral Economics: Why the Association of American Medical Colleges Is Wrong About Pharmaceutical Detailing
复制标题
DOI：
10.1080/15265160903440998
复制
发表时间：
2010-01-01
影响因子：
13.4
通讯作者：
Huddle, Thomas S.
中科院分区：
文献类型：
--
作者：
Huddle, Thomas S.
美国医学院协会（AAMC）敦促学术医疗中心禁止药物细节。这一政策是基于行为和神经经济学研究的考虑。我认为，这项研究并不能证明从中得出的结论是正确的。药品细节对医生来说有认知错误的风险，其他形式的信息交换也是如此。医生可能会克服这些风险;那些决心这样做的人可能会在道德上参与药物细节。他们是否应该这样做是一个审慎的判断，理性的人可能会不同意。AAMC对细节的道德谴责是没有根据的，并且将破坏在临床工作中维持医生自由裁量权的努力，而这种自由裁量权在我们目前的实践环境中日益受到威胁。
The Association of American Medical Colleges (AAMC) is urging academic medical centers to ban pharmaceutical detailing. This policy followed from a consideration of behavioral and neuroeconomics research. I argue that this research did not warrant the conclusions drawn from it. Pharmaceutical detailing carries risks of cognitive error for physicians, as do other forms of information exchange. Physicians may overcome such risks; those determined to do so may ethically engage in pharmaceutical detailing. Whether or not they should do so is a prudential judgment about which reasonable people may disagree. The AAMC's ethical condemnation of detailing is unwarranted and will subvert efforts to maintain a realm of physician discretion in clinical work that is increasingly threatened in our present practice environment.